Dyne Therapeutics, Inc. (DYN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 32.43 |
| Open | 32.47 |
| Bid | 32.53 x 800 |
| Ask | 32.69 x 800 |
| Day's range | 31.59 - 33.16 |
| 52-week range | 6.40 - 47.45 |
| Volume | |
| Avg. volume | 1,285,058 |
| Market cap | 3.273B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.58 |
| Earnings date | 28 Oct 2024 - 01 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 54.11 |
Simply Wall St.CEO, President & Director of Dyne Therapeutics John Cox Buys 640% More Shares
Those following along with Dyne Therapeutics, Inc. ( NASDAQ:DYN ) will no doubt be intrigued by the recent purchase of...
ZacksBiotech Stock Roundup: NVAX Vaccine Approval, ALNY, ATHA Stock Dive on Updates & More
Novavax and Alnylam are in the spotlight following drug approval and regulatory updates, respectively.
- Zacks
Dyne Reports Mixed Data From DMD Study, Key Executives Step Down
DYN's shares plummet following mixed data from its ongoing DMD study. Senior executives of the company step down.
© 2024 Yahoo. All rights reserved.